The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Cyberonics To Participate In Upcoming Investor Conferences

Tuesday, May 28, 2013

Cyberonics To Participate In Upcoming Investor Conferences

09:00 EDT Tuesday, May 28, 2013

HOUSTON, May 28, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.

Greg Browne, Cyberonics' Chief Financial Officer, will present at the Jefferies 2013 Global Healthcare Conference in New York on Thursday, June 6, 2013 at 9:00 AM Eastern Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on June 6, 2013. 

Mr. Browne, along with Milton Morris, Ph.D., Cyberonics' Senior Vice President, Research and Development, and Sherrie Perkins, Cyberonics' Vice President of Marketing and New Business Development, will present at the William Blair 33rd Annual Growth Stock Conference in Chicago on Tuesday, June 11, 2013 at 10:10 AM Central Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on June 11, 2013. 

In addition, Mr. Browne and Ms. Perkins will present at the Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes on June 12, 2013 at 1:20 PM Pacific Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on June 12, 2013.

Finally, Mr. Browne, along with Peter Donato, Cyberonics' Corporate Controller, will participate in the Northcoast Research 2013 Healthcare Forum in New York on Tuesday, June 18, 2013.  The format for this conference is one-on-one or small group meetings.  No formal presentation will be made, and the group meetings will not be webcast.

About Cyberonics, Inc. and the VNS Therapy® SystemCyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Contact InformationGreg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd.Houston, TX 77058Main:  (281) 228-7262 / Fax:  (281) 218-9332ir@cyberonics.com

SOURCE Cyberonics, Inc.

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

Digital Business Solutions
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections